Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines

被引：0
|
作者：
Hila Fishman
Roni Monin
Eyal Dor-On
Adrian Kinzel
Adi Haber
Moshe Giladi
Uri Weinberg
Yoram Palti
机构：
[1] Novocure Ltd,
[2] Novocure,undefined
[3] GmbH,undefined
来源：
Journal of Neuro-Oncology | 2023年 / 163卷
关键词：
Glioblastoma; Tumor Treating Fields (TTFields); Temozolomide; Lomustine; DNA damage;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：83 / 94
页数：11
相关论文
共 50 条
  • [1] Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Kinzel, Adrian
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    JOURNAL OF NEURO-ONCOLOGY, 2023, 163 (01) : 83 - 94
  • [2] Tumor Treating Fields (TTFields) may be utilized to increase temozolomide and lomustine efficacy in glioblastoma cell lines
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Haber, Adi
    Gastl, Bastian
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 148 - 148
  • [3] Tumor Treating Fields (TTFields) Enhance the Efficacy of Temozolomide and Lomustine in Glioblastoma Cell Lines
    Fishman, H.
    Monin, R.
    Dor-On, E.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E70 - E70
  • [4] APPLYING TUMOR TREATING FIELDS (TTFIELDS) FOR ENHANCEMENT OF TEMOZOLOMIDE AND LOMUSTINE EFFICACY IN GLIOBLASTOMA CELL LINES
    Fishman, H.
    Monin, R.
    Dor-On, E.
    Kinzel, A.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    NEURO-ONCOLOGY, 2023, 25 : 63 - 63
  • [5] Enhancing treatment efficacy of glioblastoma cell lines by adding tumor treating fields (TTFields) to temozolomide and lomustine
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Tumor Treating Fields (TTFields), temozolomide and lomustine co-application is efficacious in glioblastoma cancer cell lines
    Fishman, H.
    Monin, R.
    Dor-On, E.
    Wolfbauer, C.
    Haber, A.
    Giladi, M.
    Weinberg, U.
    Palti, Y.
    NEURO-ONCOLOGY, 2022, 24
  • [7] THE EFFICACY OF TEMOZOLOMIDE AND LOMUSTINE IN GLIOBLASTOMA CELL LINES MAY BE ENHANCED BY CONCOMITANT TREATMENT WITH TUMOR TREATING FIELDS (TTFIELDS)
    Fishman, Hila
    Monin, Roni
    Dor-On, Eyal
    Haber, Adi
    Giladi, Moshe
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2022, 24 : 92 - 92
  • [8] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaros Lazaridis
    Niklas Schäfer
    Sarah Teuber-Hanselmann
    Tobias Blau
    Teresa Schmidt
    Christoph Oster
    Johannes Weller
    Theophilos Tzaridis
    Daniela Pierscianek
    Kathy Keyvani
    Christoph Kleinschnitz
    Martin Stuschke
    Björn Scheffler
    Cornelius Deuschl
    Ulrich Sure
    Ulrich Herrlinger
    Sied Kebir
    Martin Glas
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
  • [9] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaridis, Lazaros
    Schaefer, Niklas
    Teuber-Hanselmann, Sarah
    Blau, Tobias
    Schmidt, Teresa
    Oster, Christoph
    Weller, Johannes
    Tzaridis, Theophilos
    Pierscianek, Daniela
    Keyvani, Kathy
    Kleinschnitz, Christoph
    Stuschke, Martin
    Scheffler, Bjoern
    Deuschl, Cornelius
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 787 - 792
  • [10] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, Lazaros
    Schaefer, Niklas
    Kebir, Sied
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Glas, Martin
    NEURO-ONCOLOGY, 2018, 20 : 119 - 120
12345